Join our Free Webinar
Designing a Next Generation “Smart” Biomanufacturing Facility
Flexible, single-use systems that are decreasing capital investment and infrastructure requirements
New biopharmaceutical products have great promise for improving the length and quality of people’s lives. However, this can only be achieved through efficient design and utilization of manufacturing plants and equipment. In this Webinar you will learn how the use of flexible, single-use systems across an integrated platform can help enable the achievement of this goal.
Find out why Abzena has selected Sartorius as its partner of choice for their bioproduction facility design: sign up now for this exciting webinar!
June 20, 2018 – 3PM London | 10AM New York | 4PM Berlin
For those that cannot attend the live event: registrants will be informed when the webinar is available for viewing on demand.
Key Learning Objectives
- Designing a state-of-the-art flexible single-use facility
- Developing next generation “smart” automation strategies
- Discover the value of integrated Sartorius innovative systems
About the Speakers
Miriam Monge, Marketing Director Integrated Solutions, Sartorius Stedim Biotech
Miriam is best known in the industry for her contribution during the pioneering phase of single-use disposable technologies. Her current position at Sartorius Stedim Biotech focuses on developing full bioprocess platforms based on disposable & hybrid technologies for mAbs, vaccines, ADC’s and intensified processing.
Kevin Lynch, Director Sales Integrated Solutions, Sartorius Stedim North America Inc
Kevin is a life sciences executive with over 25 years of experience. He has a proven track record of ensuring successful clinical process and IND, process technical transfers and GMP processing from PVRs through to BLA filing and site inspections. He has worked for top-tier US and European organizations including Shire, Genzyme, and Sartorius Stedim.
Dr. Jim Mills, Senior Vice President, Technical Operations, Abzena
Jim has over 20 years experience working in the biotech and biopharmaceutical sector. He has held senior management positions at Cantab biopharmaceuticals (CEO), Xenova Biomanufacturing (Director of Operations) and Xenova Research Ltd (Leader, Upstream Process Development and Technical Business Development).